Sort
23,748 grants matching “melanoma”
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
$537,878Robert J. Canter · University Of California At Davis · U01 · FY2021 · CA
EXTRAMUR RES FACIL CONST: BREAST, PROSTATE CA &MELANOMA
$537,834University Of Pennsylvania · C06 · FY2005 · RR
Dual-Mechanism Allosteric Inhibitors of ERK Signaling
$537,806Kevin N Dalby · University Of Texas At Austin · R01 · FY2022 · CA
Regulation of the Melanocyte Lineage by the AP2 Transcription Factor Family
$537,608Robert Aaron Cornell · University Of Iowa · R01 · FY2021 · AR
Pathology and Bioinformatics Core
$537,572Scott J Rodig · Massachusetts General Hospital · P01 · FY2024 · CA
Sustaining Tissue Resident Memory T cells
$537,503Yina Hsing Huang · Dartmouth College · R01 · FY2022 · CA
Sustaining Tissue Resident Memory T cells
$537,503Yina Hsing Huang · Dartmouth College · R01 · FY2025 · CA
DNA Repair, Skin Cancer and Overall Cancer Risk
$537,422Johns Hopkins University · R01 · FY2005 · CA
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
$537,316Richard J Price · University Of Virginia · R01 · FY2015 · CA
Proton-coupled folate/antifolate transport
$537,037Israel David Goldman · Albert Einstein College Of Medicine · R01 · FY2010 · CA
Tumor Microenvironment in Cancer Progression
$536,966Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$536,912Philip D Greenberg · University Of Washington · R01 · FY2015 · CA
Genetics of Complex Diseases and Health Disparities
$536,896Cheryl Winkler · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
EZH2 in cancer biology and novel inhibitors
$536,827Jun Qi · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Functional and Therapeutic Significance of PLK4 in Melanoma
$536,631Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2023 · CA
ASSESSING MOLECULAR PATHWAYS DRIVING CONJUNCTIVAL MELANOMA
$536,551Northern California Institute For Research And Education, Inc. · · FY2021 · Defense Health Agency
INTEGRINS AND OCULAR ANGIOGENESIS
$536,515Scripps Research Institute · R01 · FY2003 · EY
Immunologic Monitoring and Cellular Products Laboratory
$536,490Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
Next Gen Virotherapy for GBM
$536,442Balveen Kaur · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · NS
An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk
$536,383Joel J Hillhouse · East Tennessee State University · R01 · FY2013 · CA
Dendritic Cell Vaccination During Lymphoid Reconstitution
$536,345University Of Southern California · R01 · FY2005 · CA
Integration of Clinical and Molecular Biomarkers for Melanoma Survival
$536,127Marianne Berwick · University Of New Mexico Health Scis Ctr · P01 · FY2020 · CA
DEFINING AND TARGETING NOVEL EPIGENETIC VULNERABILITIES IN HETEROGENEOUS DRUG-RESISTANT MELANOMAS
$536,072Rector & Visitors Of The University Of Virginia · · FY2018 · Defense Health Agency
Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy
$536,024Alexander Huang · University Of Pennsylvania · R01 · FY2024 · CA
Project 1- Bioadhesive Sunscreens and Triplet-State Quenchers for Melanoma Prevention
$536,002Michael Girardi · Yale University · P50 · FY2018 · CA